69 related articles for article (PubMed ID: 21126568)
1. Investigating the enhancement of cisplatin cytotoxicity on 5637 cells by combination with mogoltacin.
Rassouli FB; Matin MM; Iranshahi M; Bahrami AR; Behravan J; Mollazadeh S; Neshati V; Kalalinia F
Toxicol In Vitro; 2011 Mar; 25(2):469-74. PubMed ID: 21126568
[TBL] [Abstract][Full Text] [Related]
2. Mogoltacin enhances vincristine cytotoxicity in human transitional cell carcinoma (TCC) cell line.
Behnam Rassouli F; Matin MM; Iranshahi M; Bahrami AR; Neshati V; Mollazadeh S; Neshati Z
Phytomedicine; 2009 Mar; 16(2-3):181-7. PubMed ID: 18707855
[TBL] [Abstract][Full Text] [Related]
3. Increasing the cisplatin cytotoxicity and cisplatin-induced DNA damage by conferone in 5637 cells.
Neshati V; Matin MM; Bahrami AR; Iranshahi M; Rassouli FB; Saeinasab M
Nat Prod Res; 2012; 26(18):1724-7. PubMed ID: 21988674
[TBL] [Abstract][Full Text] [Related]
4. Feselol enhances the cytotoxicity and DNA damage induced by cisplatin in 5637 cells.
Mollazadeh S; Matin MM; Bahrami AR; Iranshahi M; Behnam-Rassouli M; Rassouli FB; Neshati V
Z Naturforsch C J Biosci; 2011; 66(11-12):555-61. PubMed ID: 22351980
[TBL] [Abstract][Full Text] [Related]
5. The enhancement of vincristine cytotoxicity by combination with feselol.
Mollazadeh S; Matin MM; Iranshahi M; Bahrami AR; Neshati V; Behnam-Rassouli F
J Asian Nat Prod Res; 2010 Jul; 12(7):569-75. PubMed ID: 20628935
[TBL] [Abstract][Full Text] [Related]
6. Modulation of Multidrug Resistance Protein 2 Efflux in the Cisplatin Resistance Human Ovarian Carcinoma Cells A2780/RCIS by Sesquiterpene Coumarins.
Kasaian J; Mosaffa F; Behravan J; Masullo M; Piacente S; Iranshahi M
Phytother Res; 2016 Jan; 30(1):84-9. PubMed ID: 26503061
[TBL] [Abstract][Full Text] [Related]
7. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of cisplatin cytotoxicity in combination with herniarin in vitro.
Haghighitalab A; Matin MM; Bahrami AR; Iranshahi M; Haghighi F; Porsa H
Drug Chem Toxicol; 2014 Apr; 37(2):156-62. PubMed ID: 24116377
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of lexatumumab-induced apoptosis in human solid cancer cells by Cisplatin in caspase-dependent manner.
Wu XX; Kakehi Y
Clin Cancer Res; 2009 Mar; 15(6):2039-47. PubMed ID: 19276256
[TBL] [Abstract][Full Text] [Related]
10. Exogenous mutant p53 DNA enhanced cisplatin-induced apoptosis in TSGH-8301 human bladder cancer cells.
Chang FL; Ling YF; Lai MD
Anticancer Res; 2000; 20(1A):329-36. PubMed ID: 10769676
[TBL] [Abstract][Full Text] [Related]
11. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
[TBL] [Abstract][Full Text] [Related]
12. Modulating effect of mitomycin or cisplatin on lymphokine-activated killer cell proliferation and antitumor activity to bladder cancer cell lines in vitro.
Wang ZP; Qing DS; Shi BG; Chen YR; Liu GD
Zhongguo Yao Li Xue Bao; 1998 Jul; 19(4):369-72. PubMed ID: 10375787
[TBL] [Abstract][Full Text] [Related]
13. Mutant Nbs1 enhances cisplatin-induced DNA damage and cytotoxicity in head and neck cancer.
Tran HM; Shi G; Li G; Carney JP; O'Malley B; Li D
Otolaryngol Head Neck Surg; 2004 Oct; 131(4):477-84. PubMed ID: 15467621
[TBL] [Abstract][Full Text] [Related]
14. Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin.
Mizutani Y; Nakao M; Ogawa O; Yoshida O; Bonavida B; Miki T
J Urol; 2001 Jan; 165(1):263-70. PubMed ID: 11125422
[TBL] [Abstract][Full Text] [Related]
15. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of vincristine on the 5637 cell line is enhanced by combination with conferone.
Neshati V; Matin MM; Iranshahi M; Bahrami AR; Behravan J; Mollazadeh S; Rassouli FB
Z Naturforsch C J Biosci; 2009; 64(5-6):317-22. PubMed ID: 19678531
[TBL] [Abstract][Full Text] [Related]
17. Establishment of cisplatin-resistant variants of human neuroblastoma cell lines, TGW and GOTO, and their drug cross-resistance profiles.
Iwasaki I; Sugiyama H; Kanazawa S; Hemmi H
Cancer Chemother Pharmacol; 2002 Jun; 49(6):438-44. PubMed ID: 12107547
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxicity of cisplatin in bladder cancer is significantly enhanced by application of bcl-2 antisense oligonucleotides.
Schaaf A; Sagi S; Langbein S; Trojan L; Alken P; Michel MS
Urol Oncol; 2004; 22(3):188-92. PubMed ID: 15271313
[TBL] [Abstract][Full Text] [Related]
19. Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminomatous germ cell line.
Kelland LR; Mistry P; Abel G; Freidlos F; Loh SY; Roberts JJ; Harrap KR
Cancer Res; 1992 Apr; 52(7):1710-6. PubMed ID: 1312897
[TBL] [Abstract][Full Text] [Related]
20. [Enhancement effect of nucleotide excision repair gene xeroderma pigmentosun group a antisense RNA on sensitivity of human lung adenocarcinoma cell line A549 to cisplatin].
Fan W; Zhang HL; Wu XM
Ai Zheng; 2005 Apr; 24(4):403-7. PubMed ID: 15820060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
